¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"single blinding study"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
single blind study
´ÜÀϸͰ˿¬±¸
multitarget single hit model
´ÙÇ¥Àû´ÜÀÏÀûÁ߸ðµ¨
single atrium
Ȭ½É¹æ, ´Ü½É¹æ
single burst
ÀÏȸ¹æÃâ·®
single colony isolation
´ÜÀÏÁý¶ôºÐ¸®, Áý¶ô°í¸£±â
single donor platelet
ÀÏÀÎÇåÇ÷ÀÚÇ÷¼ÒÆÇ, ÀÏÀΰøÇ÷ÀÚÇ÷¼ÒÆÇ
single immunodiffusion
´ÜÀϸ鿪Ȯ»ê
single injection technique
ÀÏȸÁÖÀÔ¹ý
single interference pattern
´ÜÀϰ£¼·¾ç»ó
single investing method
ÀÏȸ¸Å¸ô¹ý
single linkage
´ÜÀÏ¿¬¼â
single major gene locus model
´ÜÀÏÁÖ¿äÀ¯ÀüÀÚÀÚ¸®¸ðÇü
single nucleotide polymorphism
´ÜÀÏ´ºÅ¬·¹¿ÀƼµå´ÙÇüÅÂ
single outlet heart
´ÜÀÏÀ¯Ãâ·Î½ÉÀå
single pass technique
ÀÏȸÅë°ú±â¹ý, ´ÜÀÏÅë°ú±â¹ý
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
single blinding study
´Ü¼ø¸Í°Ë¹ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
single vision
´ÜÀϽÃ
single ventricle
´Ü½É½Ç, Ȭ½É½Ç
study design
¿¬±¸¼³°è
study
¿¬±¸, °Ë»ç, Á¶»ç
arterial blood gas study
µ¿¸ÆÇ÷°¡½ººÐ¼®
case-control study
ȯÀÚ´ëÁ¶±º¿¬±¸
cohort study
ÄÚȣƮ¿¬±¸
cross-sectional study
´Ü¸éÁ¶»ç¿¬±¸
ecological study
»ýÅ¿¬±¸
longitudinal study
ÃßÀû¿¬±¸
observational study
°üÂû¿¬±¸
pilot study
¿¹ºñ¿¬±¸
population study
Àα¸Á¶»ç
prospective study
ÀüÇ⿬±¸, °èȹ¿¬±¸, ¾Õ¹æÇ⿬±¸, Àü¸Á¿¬±¸
prospective cohort study
ÀüÇâÄÚȣƮ¿¬±¸
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
single blind study
´ÜÀϸͰ˹ý
single atrium
Ȭ½É¹æ, ´Ü½É¹æ
single burst
ÀÏȸ¹æÃâ·®
single-agent chemotherapy
´ÜÀÏÁ¦Á¦Ç×¾ÏÈÇпä¹ý
single-step growth curve
ÀÏȸÁõ½Ä°î¼±
single fiber electrode
´ÜÀϼ¶À¯Àü±Ø
single outlet heart
´ÜÀÏÀ¯Ãâ·Î½ÉÀå
single immunodiffusion
´ÜÀϸ鿪Ȯ»ê
single colony isolation
´ÜÀÏÁý¶ôºÐ¸®, Áý¶ô°í¸£±â
single linkage
´ÜÀÏ¿¬¼â
multitarget single hit model
´ÙÇ¥Àû´ÜÀÏÀûÁ߸ðµ¨
single investing method
ÀÏȸ¸Å¸ô¹ý
single major gene locus model
´ÜÀÏÁÖ¿äÀ¯ÀüÀÚÀÚ¸®¸ðÇü
single-tube mixer
´ÜÀϽÃÇè°üÈ¥ÇÕ±â
single donor platelet
ÀÏÀΰøÇ÷Ç÷¼ÒÆÇ, ÀÏÀÎÇåÇ÷Ç÷¼ÒÆÇ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
14
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
SPECT, see single positron emission computed tomopraphy
½ºÆåÆ®(´ÜÀϾçÀÚ¹æÃâÀü»êÈ´ÜÃþÃÔ¿µ¼ú)
growth curve, single-step
ÀÏȸÁõ½Ä°î¼±
B cell study
B ¼¼Æ÷°Ë»ç
air study
°ø±â(ÁÖÀÔ) °Ë»ç(¹ý)
arterial blood gas study
µ¿¸ÆÇ÷ °¡½ººÐ¼®
infection control study
°¨¿°°ü¸®¿¬±¸
phase 1 study
ÀÓ»óÁ¦1»ó½ÃÇè.
pilot study
¿¹ºñ½ÇÇè.
population study
Àα¸Á¶»ç
preclinical study
ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
pressure flow study
¾Ð·ù·® Á¶»ç
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
prospective study
°èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
real time study
½Ç½Ã°£ °Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
single blind study
´ÜÀÏ<¼ø>¸Í°Ë¹ý.
air study
°ø±â(ÁÖÀÔ) °Ë»ç(¹ý)
arterial blood gas study
µ¿¸ÆÇ÷ °¡½ººÐ¼®
cardiac gated MR study
½ÉÀ嵿±â ÀÚ±â°ø¸í °Ë»ç
case control study
ȯÀÚ´ëÁ¶¿¬±¸.
case study
Áõ·Ê¿¬±¸(Áõ¿¹¿¬±¸).
case study
Áõ·Ê¿¬±¸(ñøçÓæÚϼ).
cohort study
ÄÚ¿ÀÆ®¿¬±¸(ÊÙËçË´), Æø·ÎºñÆø·Î¿¬±¸.
controlled clinical study
(Ãß°èÇÐÀû) °ü¸®È(̧ËÌ°ËøË´ËöÌ´)(ÀÓ»ó)½ÃÇè( ËöË×ËàÌ´).
double-blind study
ÀÌÁ߸ͰË.
family study
°¡Á·Á¶»ç(¿¬±¸)
first pass study
ÀÏÂ÷Åë°ú°Ë»ç.
follow-up study
ÃßÀûÁ¶»ç
infection control study
°¨¿°°ü¸®¿¬±¸
microbiologic study
¹Ì»ý¹°ÇÐÀû °Ë»ç
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½